I am feeling quite happy with the potential gains from a good HIV result, and I feel that the immune calming on the Covid front will place us in a good position all by itself. I have been looking over our competition and we appear to be way out in front for proven safety and pretty much the only one with a direct immune calming effect. Gotta love that!
I do appreciate that mob making progress on autophagy. If I had access to the Korean market I would send them some $ just for the health-span market possibilities. However, I don't see them as a direct competitor to BIT225 when proven, more like a useful adjunct.
You are right though. The safety results of long term dosing from so many human trials for HIV has to be placing us in a very nice position for any half decent results coming out of the Phase 2 Covid trial. Massive foot in the door, IMO.
- Forums
- ASX - By Stock
- BIT
- COVID19 - competitive landscape
COVID19 - competitive landscape, page-198
-
- There are more pages in this discussion • 161 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
4.6¢ |
Change
0.001(2.22%) |
Mkt cap ! $41.50M |
Open | High | Low | Value | Volume |
4.4¢ | 4.7¢ | 4.4¢ | $31.64K | 708.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 259000 | 4.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 17361 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 259000 | 0.045 |
1 | 200000 | 0.044 |
3 | 415000 | 0.043 |
3 | 322000 | 0.042 |
4 | 287000 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.047 | 200000 | 1 |
0.048 | 308915 | 1 |
0.050 | 21000 | 1 |
0.051 | 96225 | 3 |
0.052 | 1527335 | 2 |
Last trade - 14.10pm 21/06/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online